Morganly AI Medical Intelligence

Terms of Service

Morganly Inc.

Version 2.0

1. Introduction and Acceptance

These Terms of Service ("Terms") govern access to and use of the Morganly platform, including the website, applications, and related services (collectively, the "Services") made available by Morganly Inc., a Delaware corporation with its principal place of business in Lake Oswego, Oregon ("Morganly," "we," "us," or "our").

By accessing or using the Services, including by clicking "I Accept," completing registration, or otherwise using the Services, you represent that: (a) you have read, understood, and agree to be bound by these Terms; (b) you are a licensed healthcare professional or other authorized user acting within the scope of your professional role, or you are entering into these Terms on behalf of a healthcare organization that employs or engages such professionals; and (c) if entering on behalf of an organization, you have authority to bind that organization. "You" and "Customer" refer to the individual or organization accepting these Terms, as applicable, and "Authorized User" means any individual permitted to access the Services under a Customer's account.

If you do not agree to these Terms, you may not access or use the Services.

If your organization has entered into a separately negotiated Master Services Agreement, Enterprise Agreement, Order Form, Business Associate Agreement, or other signed written agreement with Morganly (collectively, an "Enterprise Agreement"), that Enterprise Agreement governs to the extent of any direct conflict with these Terms, and Authorized Users under that organization's account remain subject to these Terms in all other respects.

FOR U.S. CUSTOMERS: The section below titled "Dispute Resolution; Arbitration Agreement" contains an agreement to resolve disputes through binding individual arbitration, and includes a jury trial waiver and class action waiver, subject to a 30-day opt-out right described in that section. Please review it carefully.

2. Scope of Services

Morganly is a physician-facing clinical intelligence and clinical decision-support software platform built on a proprietary multi-layer reasoning framework. The Services are designed for use by licensed healthcare professionals and, where appropriate under a healthcare organization's supervision, authorized clinical or administrative staff performing functions appropriate to their role. The Services are not designed or intended for use by patients or consumers for self-diagnosis or direct clinical decision-making.

The Services allow Authorized Users to enter, upload, and analyze clinical information — including patient history, symptoms, laboratory results, medications, medical documents, clinical notes, imaging information, and other healthcare information — and may surface clinical patterns, diagnostic considerations, ranked possibilities, risk and medication-related considerations, testing and management considerations, evidence summaries, longitudinal changes, and potential next steps for the Authorized User's independent consideration (collectively, "Outputs"). The section below titled "Clinical Decision Support; Independent Professional Judgment Required" governs the use and limitations of Outputs and is incorporated into this Section by reference.

The Services are intended for use within the United States unless otherwise agreed in writing. Morganly reserves the right to limit availability of the Services to particular jurisdictions, organizations, or users at its discretion.

3. Definitions

"Authorized User" means an individual who accesses the Services under a Customer's account, including the Customer itself (if an individual), and any employees, contractors, or clinical or administrative staff of an Organizational Customer authorized to use the Services on its behalf.

"Customer" means the individual healthcare professional, practice, clinic, or healthcare organization that registers for or is otherwise granted access to the Services, and that is responsible under these Terms for its account and its Authorized Users.

"Customer Data" means clinical, patient, administrative, and other information or content that a Customer or its Authorized Users submit, upload, or input into the Services, including any Protected Health Information contained therein.

"Enterprise Agreement" means a separately negotiated and signed Master Services Agreement, Enterprise Agreement, Order Form, Business Associate Agreement, or similar written agreement between Morganly and a Customer.

"Morganly Parties" means Morganly Inc. and its affiliates, officers, directors, employees, contractors, agents, representatives, licensors, service providers, vendors, successors, and assigns.

"Outputs" means clinical patterns, diagnostic considerations, ranked possibilities, risk considerations, medication-related considerations, testing considerations, management considerations, clinical relationships, evidence summaries, longitudinal analyses, potential next steps, and other information generated or surfaced by the Services based on Customer Data and other inputs.

"Protected Health Information" or "PHI" has the meaning given to that term under HIPAA.

"Business Associate Agreement" or "BAA" means the Morganly Business Associate Agreement (as may be amended from time to time in accordance with its own terms) entered into between Morganly and a Customer that is a HIPAA Covered Entity, governing Morganly's handling of PHI.

"Subscription" means the paid or trial access plan selected by a Customer, as described on the applicable pricing page, checkout flow, or Order Form.

"Services" means the Morganly software platform, including all related websites, applications, features, and functionality made available by Morganly, excluding Third-Party Services.

4. Eligibility and Account Registration

To access certain features, you must register for an account. Registration requires accurate, current, and complete information, which may include name, work email, telephone number, professional license number, licensing state, specialty, and practice or organization information. Morganly may verify professional credentials where appropriate and may refuse to issue an account in its discretion.

You are responsible for maintaining the confidentiality of your login credentials and may not share them with any other individual. You are responsible for all activity occurring under your account. Notify Morganly promptly of any suspected unauthorized access.

Morganly may refuse, restrict, suspend, or terminate access to the Services where reasonably necessary for security, fraud prevention, credential misuse, unauthorized use, violation of these Terms, nonpayment, illegal activity, risk to Morganly or other users, or compliance with legal obligations.

5. Organizations and Authorized Users

The Services may be used by individual healthcare professionals as well as medical practices, clinics, and healthcare organizations ("Organizational Customers"). An individual who accepts these Terms on behalf of an Organizational Customer represents that they have authority to bind that organization.

Organizational Customers are responsible for their Authorized Users' compliance with these Terms and applicable law, and for ensuring that Authorized Users' access to and use of the Services is consistent with the organization's own policies, licensure requirements, and scope-of-practice limitations. If an Organizational Customer has entered into an Enterprise Agreement with Morganly, that Enterprise Agreement governs to the extent of any direct conflict with these Terms; Authorized Users remain subject to these Terms with respect to matters not addressed in the Enterprise Agreement.

6. Electronic Acceptance

Morganly uses electronic acceptance for these Terms, the BAA (where applicable), and acknowledgment of the Privacy Policy. No handwritten or notarized signature is required for standard online accounts. During account activation, you may be required to accept these documents by clicking "I Accept," "I Agree," checking a required box, or taking another affirmative electronic action.

By doing so, you consent to conduct this transaction electronically and agree that such acceptance is legally binding to the same extent as a handwritten signature, consistent with the federal E-SIGN Act and applicable state UETA laws. Morganly may record the identity of the individual accepting, the associated account and organization, the date and time of acceptance, and the version of the Terms, BAA, and other applicable agreements accepted.

7. Clinical Decision Support; Independent Professional Judgment Required

Morganly is software. Morganly is not a physician, nurse, pharmacist, laboratory, hospital, healthcare provider, or other provider of medical care, and does not practice medicine. Use of the Services does not create a physician-patient relationship, or any other healthcare provider-patient relationship, between Morganly and any patient.

Morganly provides Outputs — clinical patterns, diagnostic considerations, testing considerations, medication considerations, management considerations, and potential next steps — for the independent review and evaluation of the treating healthcare professional. Morganly does not diagnose patients, does not prescribe medications, does not order tests, imaging, or procedures, does not determine treatment, and does not independently recommend that any particular clinical action be taken. Where an Output presents a possible diagnosis, medication issue, test, treatment option, risk, or next step, that Output is information for the Authorized User to consider and evaluate using their own independent clinical judgment — it is not Morganly making a clinical decision.

Outputs may be incorrect. Morganly uses artificial intelligence and computational systems, which may produce errors, omissions, incorrect conclusions, incomplete or outdated information, inappropriate associations, misinterpretations, fabricated content, or other inaccuracies (including so-called "AI hallucinations"). Morganly does not guarantee that any Output is accurate, complete, current, clinically appropriate, or applicable to a particular patient.

The treating healthcare professional must independently review and evaluate every Output before acting on it, using the complete patient record, their own examination and knowledge of the patient, current medical evidence, applicable professional standards, their training and experience, and any other clinically relevant information. The Services must never be relied upon as the sole basis for a diagnosis, treatment decision, or other patient-care decision. The healthcare professional remains solely responsible for diagnosis, treatment, prescribing, medication changes, laboratory and imaging orders, procedures, referrals, monitoring, interpretation of patient information, verification of clinically important information, and determining whether a given Output applies to a particular patient — and for all other clinical decisions.

The Services are not designed to replace emergency medical care. The healthcare professional remains solely responsible for determining when emergency evaluation or other urgent intervention is necessary, regardless of any Output.

8. Protected Health Information; Business Associate Agreement

If Customer is a "Covered Entity" as defined by the Health Insurance Portability and Accountability Act ("HIPAA") and uses the Services to create, receive, maintain, or transmit Protected Health Information, such PHI will be handled by Morganly in accordance with the Morganly Business Associate Agreement, which is incorporated into these Terms by reference. If Customer is accessing the Services under an Enterprise Agreement that includes a separately executed Business Associate Agreement, that Business Associate Agreement governs the use and disclosure of PHI transmitted through the Services, to the extent of any inconsistency with this Section.

If these Terms conflict with the BAA regarding the use, disclosure, safeguarding, retention, return, or disposal of PHI, the BAA controls. The use, disclosure, safeguarding, retention, return, and disposal of PHI are governed by the applicable Morganly Business Associate Agreement.

Customer is responsible for having the legal right and appropriate authority to submit patient information and other Customer Data to the Services, and for its own compliance with HIPAA, other applicable privacy laws, professional obligations, medical records laws, and its organization's policies.

9. Data Use; Artificial Intelligence Training

Morganly will not use identifiable PHI to train, fine-tune, or otherwise improve any general-purpose model, foundation model, Morganly-developed model, or third-party AI model. Identifiable PHI is not used for model-training purposes.

Morganly may use properly de-identified information (de-identified in accordance with the applicable standard under the BAA and HIPAA) and aggregate or usage-level information for lawful purposes consistent with the BAA and the Morganly Privacy Policy, including analytics, security, platform performance, and service improvement, provided such use does not identify the applicable patient or Customer where de-identification is required.

As between Morganly and Customer, Customer retains ownership of Customer Data. Morganly receives only the licenses reasonably necessary to host, process, transmit, analyze, reproduce, and otherwise use Customer Data to provide, secure, and support the Services, comply with applicable law, and fulfill other purposes expressly permitted under these Terms, the BAA, or an applicable Enterprise Agreement. Morganly does not acquire, and this Section does not grant, any broader ownership interest in Customer Data.

10. Subscriptions; Fees; Free Trial

Morganly offers subscription-based access to the Services on the plans, pricing, and billing frequency described on the applicable pricing page, checkout screen, Order Form, or other offer presented to Customer at signup or renewal (as applicable, the "Plan"). Current publicly listed Individual pricing is available on Morganly's pricing page; Practice and Enterprise pricing may be separately quoted. Morganly may modify its pricing and Plans prospectively; pricing in effect at the time of a given Subscription term applies for that term unless otherwise stated.

Morganly may offer eligible new Customers a seven (7) day free trial, or another trial or promotional period as expressly disclosed during signup. A valid payment method is required to begin a trial. The payment method will not be charged during the trial period. If Customer does not cancel before the trial expires, the Subscription automatically converts to the selected paid Plan, and the payment method on file will be charged the applicable price for that Plan, on and after the date the trial ends. Before the trial converts, Morganly will present the trial duration, the selected Plan, the price, the billing frequency, the date of first charge, and the fact that the Subscription will automatically renew. Morganly may modify or discontinue trial offers prospectively, and may offer existing or legacy Customers continued access under previously purchased subscription periods or promotional terms without requiring a new payment method until such period expires.

11. Automatic Renewal; Cancellation

Monthly Subscriptions automatically renew each month, and annual Subscriptions automatically renew each year, unless canceled before the applicable renewal date through the cancellation method Morganly makes available (such as in-account settings or written notice to Morganly). Canceling stops the next renewal charge. Except as required by law or expressly stated otherwise, fees already paid for the current Subscription period are non-refundable, and cancellation does not entitle Customer to a prorated refund for the remainder of a paid period. Customer retains access through the end of the then-current paid period unless the account is suspended or terminated for cause, security intervention is required, or applicable law requires otherwise.

12. Payment Processing

Morganly uses third-party payment processors (such as Stripe) to process payments, and does not itself store complete payment card information except as handled by such processors. By providing a payment method, Customer authorizes the applicable payment processor to charge that payment method for Subscription fees, renewals, approved upgrades, applicable taxes, and other charges expressly authorized under the selected Plan. Morganly may suspend paid functionality if a payment fails, after reasonable attempts to resolve the issue with Customer.

13. License Grant

Subject to Customer's and its Authorized Users' compliance with these Terms, Morganly grants Customer a limited, revocable, non-exclusive, non-transferable, non-sublicensable right to access and use the Services during the applicable Subscription or other authorized access period, solely for legitimate professional healthcare-related purposes consistent with these Terms.

14. Prohibited Uses

Customer and its Authorized Users will not, and will not permit any third party to:

  • reverse engineer, decompile, disassemble, or otherwise attempt to discover the source code, underlying architecture, or prompting or orchestration systems of the Services;
  • copy, clone, or create a product or service competitive with the Services;
  • systematically extract Outputs to build competitive datasets, or scrape, harvest, or use automated means to extract data from the Services without authorization;
  • benchmark the Services for publication or competitive purposes without Morganly's prior written authorization;
  • attempt model extraction, prompt extraction, or other means of circumventing the Services' technical or security safeguards;
  • attempt to gain unauthorized access to the Services or related systems, share login credentials, or permit use of an account by anyone other than the registered Authorized User;
  • introduce malware or other harmful code, conduct security testing without authorization, or take any action that could disable, overburden, or impair the Services;
  • use the Services unlawfully, outside the scope of their professional license or authority, or in violation of applicable professional, privacy, medical, or healthcare laws;
  • misrepresent Outputs as independently verified medical conclusions rather than considerations for professional evaluation;
  • resell, sublicense, or otherwise provide third-party access to the Services without Morganly's authorization; or
  • submit patient information without appropriate legal authority to do so.

Nothing in this Section is intended to restrict the ordinary, good-faith clinical use of the Services by an Authorized User acting within their professional role.

15. Intellectual Property

Except for Customer Data, Morganly and its licensors own all right, title, and interest in and to the Services and underlying technology, including the software, source and object code, interfaces, design, workflows, clinical reasoning architecture, prompting and orchestration systems, algorithms, methods, documentation, branding, trademarks, logos, system architecture, platform configuration, Morganly-created data structures, clinical intelligence frameworks, and all improvements and derivative technology (collectively, "Morganly IP"). All rights not expressly granted in these Terms are reserved.

Customer's ownership of its patient and clinical data, as described in Section 9 ("Data Use; Artificial Intelligence Training") above, is separate from and unaffected by Morganly's ownership of Morganly IP. Morganly does not claim ownership of Customer's medical records or other Customer Data merely because they are processed through the Services.

16. Feedback

If Customer or an Authorized User voluntarily provides ideas, suggestions, feature requests, comments, or other feedback regarding the Services ("Feedback"), Morganly may use such Feedback for any purpose, including to improve the Services, without compensation or other obligation to the provider of the Feedback. This Section does not give Morganly any rights to identifiable PHI or other confidential clinical data beyond what is expressly permitted under these Terms, the BAA, or an applicable Enterprise Agreement.

17. Third-Party Services and Technology

The Services rely on, and may integrate with, third-party technologies, including cloud hosting, databases, document-processing services, AI infrastructure, payment processors, medical information sources, and, where applicable, EHR, laboratory, imaging, referral, or prior-authorization systems ("Third-Party Services"). Certain functionality may depend on the availability of Third-Party Services. Morganly is not responsible for outages, acts, omissions, or changes made by independent Third-Party Services beyond Morganly's reasonable control.

Where a Morganly subcontractor processes PHI on Morganly's behalf, Morganly's obligations with respect to that subcontractor remain governed by the BAA and applicable law; nothing in this Section limits Morganly's HIPAA obligations. Third-party integrations configured by Customer may be subject to their own separate terms and privacy practices, for which Morganly is not responsible.

18. Service Modifications; Availability

Morganly may update, improve, modify, add, remove, or replace features of the Services over time. Morganly does not guarantee that any particular feature will remain available indefinitely, and will not eliminate the Services for paying Customers without providing a reasonable opportunity to use or discontinue the Subscription consistent with Section 11 ("Automatic Renewal; Cancellation").

The Services may occasionally be unavailable due to scheduled or emergency maintenance, updates, third-party outages, internet or infrastructure failures, security events, force majeure, or other technical issues. Except as otherwise provided in a separate enterprise service-level agreement, Morganly does not guarantee uninterrupted or error-free availability of the Services.

19. Security

Morganly maintains administrative, physical, and technical safeguards appropriate to the Services, consistent with the BAA (for PHI) and applicable law. Morganly does not guarantee that the Services will be free from unauthorized access, and no security measure is perfect. Customer and its Authorized Users are responsible for securing their own devices, account credentials, email accounts, networks, and workstations, and must promptly notify Morganly of any suspected unauthorized access to an account.

20. Customer Responsibility for Content

Customer is solely responsible for having the legal right and appropriate authority to provide patient information and other Customer Data to the Services, and for its and its Authorized Users' compliance with HIPAA and other applicable privacy and medical-records laws, professional obligations, and organizational policies in connection with such use. Nothing in these Terms requires a separate patient authorization where HIPAA does not otherwise require one for treatment or healthcare-operations activity performed through a business associate such as Morganly. Morganly's handling of PHI remains governed by the BAA as described in Section 8.

21. Confidentiality

Each party may disclose non-public business, technical, financial, or proprietary information to the other in connection with the Services ("Confidential Information"). Each party will use the other's Confidential Information only as necessary to perform under these Terms, and will protect it using at least the same degree of care it uses to protect its own confidential information of a similar nature, but no less than a reasonable degree of care. Confidential Information does not include information that is or becomes public through no fault of the receiving party, was already known to the receiving party without a duty of confidentiality, or is independently developed. This Section does not limit or modify Morganly's specific obligations with respect to PHI under the BAA, which control for PHI as described in Section 8.

22. Indemnification

To the fullest extent permitted by applicable law, Customer will defend, indemnify, and hold harmless the Morganly Parties from and against any third-party claims, liabilities, damages, losses, judgments, settlements, penalties, fines, and reasonable costs and attorneys' fees arising from or relating to:

  • Customer's or an Authorized User's misuse of the Services;
  • breach of these Terms;
  • violation of applicable law or professional obligations;
  • unauthorized or unlawful submission of patient information, or failure to have the rights or permissions necessary for information submitted to the Services;
  • any diagnosis, treatment, prescription, medication change, test or imaging order, procedure, referral, monitoring decision, or other patient-care decision made by Customer or an Authorized User;
  • failure to independently evaluate Outputs, or use of Outputs contrary to these Terms;
  • Customer-configured third-party integrations;
  • privacy violations caused by Customer or its Authorized Users;
  • intellectual property violations arising from Customer Data; or
  • fraud, gross negligence, or willful misconduct by Customer or an Authorized User.

Morganly may assume control of the defense of any indemnified claim with counsel of its choosing, in which case Customer will cooperate with Morganly's defense. Customer will not settle any such claim in a manner that admits liability on behalf of, creates obligations for, or otherwise adversely affects any Morganly Party, without Morganly's prior written consent.

23. Disclaimer of Warranties

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE SERVICES AND ALL OUTPUTS ARE PROVIDED "AS IS" AND "AS AVAILABLE," WITHOUT WARRANTIES OF ANY KIND, WHETHER EXPRESS, IMPLIED, OR STATUTORY, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT, EXCEPT TO THE EXTENT SUCH WARRANTIES CANNOT BE DISCLAIMED UNDER APPLICABLE LAW. WITHOUT LIMITING THE FOREGOING, MORGANLY DOES NOT WARRANT THAT OUTPUTS WILL BE ACCURATE, COMPLETE, CURRENT, OR CLINICALLY APPROPRIATE FOR ANY PARTICULAR PATIENT; THAT OUTPUTS WILL IDENTIFY EVERY CONDITION, MEDICATION ISSUE, OR RISK; THAT THE SERVICES WILL BE UNINTERRUPTED OR ERROR-FREE; OR THAT ANY SPECIFIC CLINICAL RESULT OR PATIENT OUTCOME WILL OCCUR.

Medicine is complex, clinical information can be incomplete, and artificial intelligence systems are probabilistic. Morganly is sophisticated clinical decision-support software, but every Output must be independently evaluated by the treating healthcare professional, as described in Section 7 ("Clinical Decision Support; Independent Professional Judgment Required").

24. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT WILL ANY MORGANLY PARTY BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, OR FOR ANY LOSS OF PROFITS, REVENUE, BUSINESS, GOODWILL, OR DATA (WHERE SUCH LOSS OF DATA MAY LAWFULLY BE EXCLUDED), ARISING OUT OF OR RELATING TO THESE TERMS OR THE SERVICES, REGARDLESS OF THE THEORY OF LIABILITY AND EVEN IF A MORGANLY PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE TOTAL AGGREGATE LIABILITY OF THE MORGANLY PARTIES ARISING OUT OF OR RELATING TO THESE TERMS OR THE SERVICES WILL NOT EXCEED THE AMOUNTS ACTUALLY PAID BY CUSTOMER TO MORGANLY FOR THE SERVICES DURING THE TWELVE (12) MONTHS IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO THE CLAIM.

These limitations apply to the maximum extent permitted by applicable law and are not intended to disclaim any liability that applicable law does not permit Morganly to disclaim.

25. Professional Responsibility

Each Authorized User is responsible for meeting the applicable standard of care; maintaining appropriate licensure; practicing within the scope of their license; complying with the laws of the jurisdiction in which they practice; following their employer's or organization's policies; determining whether use of the Services is appropriate in a given context; and independently verifying clinically important information. Morganly does not warrant that use of the Services by a particular healthcare professional is permitted in every jurisdiction, healthcare system, hospital, clinic, or professional context, and Customer is responsible for confirming the permissibility of such use.

26. Not Intended for Patient Use

The Services are not intended for direct use by patients or consumers. A patient should not use the Services to independently diagnose themselves, select or change treatment, change medication, delay seeking medical care, or make emergency decisions. These Terms govern use of the Services by Authorized Users in their professional capacity; any patient-facing functionality offered by Morganly in the future will be subject to separate terms.

27. Term; Suspension; Termination

These Terms remain in effect for as long as Customer maintains an account or otherwise uses the Services. Morganly may suspend or terminate access to the Services for reasons including material breach of these Terms, unlawful use, security threats, fraud, credential misuse, nonpayment, risk to patients, users, or the platform, legal requirements, or professional eligibility concerns.

Customer may cancel its Subscription at any time as described in Section 11 ("Automatic Renewal; Cancellation"). Upon ordinary voluntary cancellation, Customer generally retains access through the end of the then-current paid term.

28. Effect of Termination; Data Export

Upon termination, Customer’s right to access the Services ends, except as necessary to exercise any applicable data-retrieval or export rights. With respect to PHI, all retrieval, return, retention, and disposal rights, obligations, procedures, and timeframes are governed exclusively by the applicable Morganly Business Associate Agreement. These Terms do not create a separate or conflicting retention or deletion timeline for PHI.

29. Changes to These Terms

Morganly may update these Terms from time to time. For non-material changes, Morganly will post the updated Terms with a revised effective date. For material changes, Morganly will provide reasonable advance notice (such as by email or in-Service notice). For changes materially affecting clinical-use obligations, privacy or data-use practices, dispute resolution, or material subscription obligations, Morganly may require affirmative re-acceptance before continued use of the Services. Continued use of the Services after the effective date of any update constitutes acceptance of the updated Terms. Changes to these Terms do not amend the BAA, which is revised only through its own re-acceptance process.

30. Governing Law

These Terms are governed by the laws of the State of Oregon, without regard to its conflict-of-laws principles, except as otherwise required by applicable law.

31. Dispute Resolution; Arbitration Agreement

Informal Resolution. Before filing an arbitration demand or small-claims action, the parties agree to first attempt in good faith to resolve any dispute arising out of or relating to these Terms or the Services (a "Dispute") through informal negotiation. The party raising a Dispute will provide written notice to the other party describing the Dispute; the parties will then have thirty (30) days to attempt to resolve it informally before either party may proceed to arbitration or small-claims court.

Agreement to Arbitrate. If the parties are unable to resolve a Dispute informally, and subject to the opt-out right below, Customer and Morganly agree that the Dispute will be resolved by binding, individual arbitration rather than in court, except that either party may bring a qualifying claim in small-claims court, and either party may seek injunctive or other equitable relief in court for actual or threatened infringement or misappropriation of intellectual property rights.

Jury Trial and Class Action Waiver. CUSTOMER AND MORGANLY EACH WAIVE ANY RIGHT TO A JURY TRIAL AND AGREE THAT ANY ARBITRATION OR PROCEEDING WILL BE CONDUCTED ONLY ON AN INDIVIDUAL BASIS AND NOT AS A CLASS, COLLECTIVE, OR REPRESENTATIVE ACTION. The arbitrator may not consolidate more than one party's claims and may not otherwise preside over any form of a representative or class proceeding.

Procedure. Arbitration will be administered by a mutually agreed arbitration provider under its rules then in effect, before a single arbitrator, and will take place in Oregon or remotely, as the parties agree or as the arbitral rules provide. The arbitrator's decision will be final and binding, subject only to the limited grounds for review available under the Federal Arbitration Act. Each party will bear its own attorneys' fees and costs except as the arbitrator may otherwise award under applicable law or the arbitral rules.

30-Day Opt-Out. Customer may opt out of this arbitration agreement by sending written notice to Morganly at the address in Section 33 ("Notices") within thirty (30) days of first becoming subject to this arbitration agreement, stating Customer's name, account information, and an unequivocal statement of intent to opt out. If Customer opts out, all other provisions of these Terms remain in effect, and any Dispute will instead proceed in the state or federal courts located in Oregon.

32. General Provisions

Assignment. Customer may not assign or transfer these Terms without Morganly's prior written consent; Morganly may assign or transfer these Terms without restriction, including in connection with a merger, acquisition, or sale of assets. These Terms bind and benefit the parties and their permitted successors and assigns.

Severability. If any provision of these Terms is held invalid or unenforceable, that provision will be construed to reflect, as closely as possible, the parties' original intent, and the remaining provisions will remain in full force and effect.

Waiver. Failure to enforce any provision of these Terms is not a waiver of the right to enforce it later.

Force Majeure. Neither party is liable for delay or failure to perform caused by circumstances beyond its reasonable control, including natural disasters, acts of government, internet or infrastructure failures, or third-party service outages.

Independent Parties. The parties are independent contractors. Nothing in these Terms creates a partnership, joint venture, agency, or employment relationship.

No Third-Party Beneficiaries. Except as expressly provided in the BAA or an Enterprise Agreement, these Terms do not create any rights for any person or entity that is not a party to them.

Entire Agreement; Order of Precedence. These Terms, together with the BAA (where applicable) and any applicable Enterprise Agreement, constitute the entire agreement between the parties regarding the Services and supersede all prior discussions regarding the Services. In the event of a conflict: (a) for matters concerning the use, disclosure, safeguarding, retention, return, or disposal of PHI, the BAA controls; (b) for matters addressed in a signed Enterprise Agreement, that Enterprise Agreement controls to the extent of the direct conflict; and (c) otherwise, these Terms control.

Electronic Communications. Communications between Customer and Morganly may occur electronically. Customer consents to receive communications electronically and agrees that electronic communications satisfy any legal requirement that such communications be in writing, consistent with the federal E-SIGN Act.

Survival. Provisions that by their nature should survive termination — including Intellectual Property, Confidentiality, Indemnification, Disclaimer of Warranties, Limitation of Liability, Dispute Resolution, and General Provisions — survive termination of these Terms.

Headings; Interpretation. Section headings are for convenience only and do not affect interpretation. "Including" means "including without limitation."

33. Notices

Notices to Morganly must be sent in writing to [Morganly Inc.'s official legal notice / mailing address 5200 Meadows Rd. Ste 150 Lake Oswego, OR 97035], Attn: Legal Department, or to such other address as Morganly designates. Notices to Customer will be sent to the email address associated with Customer's account. Notices are deemed given when received.

Effective Date: October 12, 2026